Top 5 Oncology Articles in 2023
This year's top oncology news included a study that suggested low-fat meals could affect blood concentration levels, and high blood concentration has been associated with a better response to the drug, Alecensa.
- For Alecensa, ‘Take With Meal’ May Have a Caveat
Study suggests that low-fat meals may affect blood concentration levels, and high blood concentration has been correlated with a better response to the drug.
Read here - ‘Thrilling’ Finding: Daily Tagrisso Halves Risk of Death in Some Lung Cancer Patients
Findings from the ADAURA trial argue for starting treatment with the AstraZeneca drug early, says Yale’s Roy Herbst, M.D., Ph.D., the principal investigator.
Read here - Looking Out for the Ocular Side Effects of the Immune Checkpoint Inhibitors
Side effects from Opdivo, Yervoy and Keytruda that affect the eyes are relatively rare but can be serious. A recent review identified 290 cases.
Read here - Esophageal Cancer Update
Gastroesophageal reflux disease is a risk factor for what is now the more common type of esophageal cancer, adenocarcinoma. Immunotherapy is coming on strong as a treatment.
Read here - Is Medicare Advantage a Disadvantage For Patients With Cancer?
Medicare Advantage plans have been associated with increased screening rates. But managed care tactics and narrow networks may be a disadvantage for people needing care.
Read here
Today, the clade 2b outbreak has reached alarming proportions, with over 94,000 confirmed cases reported across 117 countries, including significant numbers in the U.S. and Brazil, and up to 103 deaths. The virus has been found to affect younger men who have sex with men, who are linked to high rates of HIV co-infection.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
